As we head into a long Thanksgiving weekend (in the US at least), I thought I’d write a quick thank you to everyone who has supported this blog in 2009. It has far exceeded my expectations and I continue to be amazed and flattered by the comments I receive via email, Twitter, and, more recently, in person. I launched this blog very late in 2008 with a few test posts, but really started dedicating time to at the beginning of this year. As a special thanks, read through to the end to get a special offer for all my dedicated readers (and if you’re reading this during Thanksgiving break, you’re dedicated).
This is a teaser of Dose of Digital: The Year So Far
. Click here to read the full post: (843 words, 1 image, ~3:22 minutes reading time)
It’s almost been almost a week since the FDA hearings on social media wrapped up. If you missed it, then you missed a bit of history. Well, you sort of missed a bit of history. It’s not the fall of the Berlin Wall or anything, but it’s pretty rare that the FDA has a hearing like this. I’m not going to begin to try to give you all the links you need to review what happened and instead I’m going to point you to the source for the latest and greatest on all things FDA social media, the #FDASM site created by Fabio Gratton. That’s where you can get links to all the presentations, the Twitter feed of the #FDASM hashtag, downloadable copies of many of the presentations, and a lot more.
This is a teaser of Three Things I Learned at the FDA Social Media Hearings and Three I Wish I Had
. Click here to read the full post: (553 words, ~2:13 minutes reading time)
In honor of tomorrow’s FDA social media hearings, I thought it would be a great time to update the Pharma and Healthcare Social Media Wiki. While many companies remain on the sidelines of social media, others are passing them by. The wiki has hundreds of examples of pharma and healthcare companies using social media TODAY. No hearing required. No special permission. No guidelines.
So, study up before the hearing and see what people are doing now. One thing to keep in mind for all the conservative regulatory and legal folks out there: not a single program on this wiki (now over 250 industry examples alone) has ever gotten a warning letter. You heard that right. Not one.
This is a teaser of November Pharma and Healthcare Social Media Wiki Updates
. Click here to read the full post: (570 words, 2 images, ~2:17 minutes reading time)
With just a few days until the long awaited FDA hearings on pharma’s use of social media, the buzz in our little community has certainly picked up. Heck, there’s even a site to track it all courtesy of Fabio Gratton. If you want the latest about these hearings, this site is a pretty good place to start. You can get a bunch of logistics information, see the Twitter buzz, and even download the presentations of those people who have made them available (you can get mine here).
This is a teaser of 166 Reportable Adverse Events Equals One Red Herring
. Click here to read the full post: (2048 words, 2 images, ~8:12 minutes reading time)
It’s almost that time. One more week until the FDA hearings that everyone has demanding for more than a year. As a refresher, on November 12-13, the FDA is holding a public hearing on the use of social media by pharma and medical device companies (and others). Officially, the title of the hearing is: Promotion of Food and Drug Administration-Regulated Medical Products Using the Internet and Social Media Tools (Document ID FDA-2009-N-0441-0001).
I recently posted the agenda for the meeting, but it has been updated. You can download the new agenda here:
This is a teaser of A Sneak Preview of My FDA Social Media Hearing Testimony
. Click here to read the full post: (1071 words, ~4:17 minutes reading time)
